Data: Fair
Artocarpus Lakoocha (Monkey Fruit) Wood Extract
- Products with this ingredient are allowed for use in EWG VERIFIED but must meet use restrictions and warnings based on EWG review of company data.
- This ingredient's score is higher if used in product forms that are inhalable (e.g., sprays, powders) because of respiratory concerns. The score is lower if used in product forms that have lower risk of inhalation (e.g., solids, liquids)
- This ingredient's score is higher if used in products that may not meet industry safety guidelines or U.S. and international government requirements. The score will be lower if used in products that meet these safety guidelines and requirements.
Other Concerns
Enhanced skin absorption, Use restrictions (high), Neurotoxicity (low), Endocrine disruption (moderate), Non-reproductive organ system toxicity (low_moderate), Multiple, additive exposure sources (moderate), Ecotoxicology (low), Irritation (skin, eyes, or lungs) (high), Occupational hazards (moderate), and Biochemical or cellular level changes (low)SYNONYMS
EWG VERIFIED CRITERIA
Restricted: EWG VERIFIED products cannot contain this ingredient without adequate substantiation.
Artocarpus Lakoocha Wood Extract is the extract of the wood of Artocarpus lakoocha, Moraceae
Common concerns
See how this product scores for common concerns.
-
LOWCancer
-
MODERATEAllergies & Immunotoxicity
-
LOWDevelopmental and Reproductive Toxicity
-
HIGHUse Restrictions
Ingredient concerns
- CONCERNS
- DATA SOURCES
Products with this Ingredient
| facial cleanser | 1 products |
Ecotoxicology
| CONCERN | REFERENCE |
|---|---|
| Wildlife and environmental toxicity | EU GHS Hazard Labeling Codes |
| Wildlife and environmental toxicity | Environmental Protection Agency (EPA) |
| Not suspected to be an environmental toxin | Environment Canada |
| Limited evidence of environmental toxicity | European Chemicals Agency (ECHA) |
| Suspected to be an environmental toxin | Peer Reviewed Literature |
Irritation (skin, eyes, or lungs)
| CONCERN | REFERENCE |
|---|---|
| Classified as any irritant | EU GHS Hazard Labeling Codes |
| Classified as eye and skin irritant | EU GHS Hazard Labeling Codes |
| Limited evidence of Skin irritation | European Chemicals Agency (ECHA) |
| Limited evidence of Lung irritation | European Chemicals Agency (ECHA) |
Organ system toxicity (non-reproductive)
| CONCERN | REFERENCE |
|---|---|
| Classified as toxic or harmful | EU GHS Hazard Labeling Codes |
| Classified as not expected to be potentially toxic or harmful | Environment Canada |
| Classified as a low human health priority | Environment Canada |
| Classified as expected to be toxic or harmful | Environment Canada |
| Classified as medium human health priority | Environment Canada |
| reproductive - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | US. National Library of Medicine, |
| Limited evidence of cardiovascular or blood toxicity | US. National Library of Medicine, |
| Limited evidence of gastrointestinal or liver toxicity | US. National Library of Medicine, |
| One or more animal studies show any effects at moderate doses (low dose studies may be unavailable for this ingredient) | Environmental Protection Agency (EPA) |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | Environmental Protection Agency (EPA) |
| Associated with occular toxicity | European Chemicals Agency (ECHA) |
| Classified as toxic or harmful. | European Chemicals Agency (ECHA) |
| Associated with toxicity | Peer Reviewed Literature |
| Limited evidence of toxicity | Peer Reviewed Literature |
| Classified as potentially toxic or harmful | Peer Reviewed Literature |
Occupational hazards
| CONCERN | REFERENCE |
|---|---|
| Allowed workplace exposures restricted to low doses | EU GHS Hazard Labeling Codes |
Use restrictions
| CONCERN | REFERENCE |
|---|---|
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | Health Canada |
| Violation of government restrictions - Restricted in cosmetics; use, concentration, or manufacturing restrictions - any | EU Cosmetics Directive |
| Determined safe for use in cosmetics, subject to concentration or use limitations - any | Personal Care Products Council |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in cosmetics (concentration limit) | Japan Ministry of Health |
Data gaps
| CONCERN | REFERENCE |
|---|---|
| Risk assessment method deficiencies and data gaps - Maximum reported 'as used' concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | Cosmetic Ingredient Review (CIR) |
| Safety assessment was based on related chemical | Cosmetic Ingredient Review (CIR) |
Informational
| CONCERN | REFERENCE |
|---|---|
| Industry or government recommendations for safe use: restrictions on concentration, impurities, product types, or manufacturing methods - any | Cosmetic Ingredient Review (CIR) |
| Industry or government recommendations for safe use: restrictions on concentration, impurities, product types, or manufacturing methods - Color Additives - Hair Dye | Personal Care Products Council |
Multiple, additive exposure sources
| CONCERN | REFERENCE |
|---|---|
| Designated as safe for general or specific, limited use in food | US. Food and Drug Administration (FDA) |
| Moderate human health concern based on exposure and toxicity | Phthalates and Cumulative Risk Assessment The Task Ahead(2008-01-01) |
Persistence and bioaccumulation
| CONCERN | REFERENCE |
|---|---|
| Not suspected to be bioaccumulative | Environment Canada |
| Not suspected to be persistent | Environment Canada |
Endocrine disruption
| CONCERN | REFERENCE |
|---|---|
| Human endocrine disruptor - strong evidence | European Union |
| endocrine - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | Our Stolen Future |
| Associated with endocrine disruption | The estrogenic activity of phthalate esters in vitro(1997-08-01) |
| Associated with endocrine disruption | Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k(2005-04-01) |
| Associated with endocrine disruption | Evaluation of estrogenic activity of phthalate esters by gene expression profiling using a focused microarray (EstrArray)(2008-06-01) |
| Limited evidence of disruption | Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans(2008-10-01) |
| Associated with endocrine disruption | Environmental Protection Agency (EPA) |
| Limited evidence of disruption | Peer Reviewed Literature |
Allergies/immunotoxicity
| CONCERN | REFERENCE |
|---|---|
| Human skin toxicant or allergen - strong evidence | Peer Reviewed Literature |
| Limited evidence of immune system toxicity or allergies | US. National Library of Medicine, |
| Limited evidence of dermal toxicity or allergies | European Chemicals Agency (ECHA) |
| Associated with immunotoxicity or allergies | Peer Reviewed Literature |
Cancer
| CONCERN | REFERENCE |
|---|---|
| Cancer - limited evidence | Personal Care Products Council |
| Not likely to be carcinogenic in humans | International Agency for Research on Cancer (IARC) |
| Cancer - weight of evidence unknown/unassessed | European Chemicals Agency (ECHA) |
Developmental/reproductive toxicity
| CONCERN | REFERENCE |
|---|---|
| Limited evidence of toxicity | US. National Library of Medicine, |
Biochemical or cellular level changes
| CONCERN | REFERENCE |
|---|---|
| One or more animal studies show changes at moderate doses where the human health implications are not yet well understood | Peer Reviewed Literature |
Neurotoxicity
| CONCERN | REFERENCE |
|---|---|
| One or more animal studies show effects at high doses | Peer Reviewed Literature |
- EU GHS Hazard Labeling Codes
- Environmental Protection Agency (EPA)
- Environment Canada
- European Chemicals Agency (ECHA)
- Peer Reviewed Literature
- US. National Library of Medicine,
- Health Canada
- EU Cosmetics Directive
- Personal Care Products Council
- Japan Ministry of Health
- Cosmetic Ingredient Review (CIR)
- US. Food and Drug Administration (FDA)
- Phthalates and Cumulative Risk Assessment The Task Ahead(2008-01-01)
- European Union
- Our Stolen Future
- The estrogenic activity of phthalate esters in vitro(1997-08-01)
- Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k(2005-04-01)
- Evaluation of estrogenic activity of phthalate esters by gene expression profiling using a focused microarray (EstrArray)(2008-06-01)
- Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans(2008-10-01)
- International Agency for Research on Cancer (IARC)
Understanding scores
Cosmetics and personal care products are not required to be tested for safety before being allowed on the market. The Skin Deep® scoring system was designed to help the public understand whether a product is safe to use or whether it contains ingredients of concern.
Every product and ingredient in Skin Deep gets a two-part score – one for hazard and one for data availability. The safest products score well by both measures, with a low hazard rating and a fair or better data availability rating.
HOW WE DETERMINE SCORES
Hazard score
The Skin Deep ingredient hazard score, from 1 to 10, reflects known and suspected hazards linked to the ingredients. The EWG Verified® mark means a product meets EWG’s strictest criteria for transparency and health.
Data availability
The Skin Deep data availability rating reflects the number of scientific studies about the product or ingredient in the published scientific literature.